Posts Tagged ‘patent’

Biologic data exclusivity: The arguments for and against it

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology: Why data exclusivity is the new patent protection Peter J Pitts, Center for medicine in the public interest Follow-on biologic drug competition […]


Assessing India’s Innovation Climate

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products must “differ significantly in properties with regard to efficacy.” This requirement for a significant improvement in efficacy only applies to drugs — not to other patentable inventions like pens, car engines, etc., and is of […]


Drug Patent Expirations in November 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in November 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ALKERAN Glaxosmithkline melphalan hydrochloride 4,997,651 Nov 18, 2008 BREVIBLOC Baxter Hlthcare Corp esmolol hydrochloride 5,017,609 Nov 21, 2008 BUSPAR Bristol Myers Squibb buspirone hydrochloride 5,015,646 Nov 14, 2008 COVERA-HS Gd Searle […]


Intellectual Property Theft on the Rise

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Intellectual Property Theft on the Rise By John Avellanet, Managing Director and Principal of Cerulean Associates LLC Reprinted with permission from SMARTERCOMPLIANCE™ 2(9): p 1-2 (September 2008) Nine out of ten companies do not have appropriate policies and controls in place to stop […]


Drug Patent Expirations in October 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in October2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration CASODEX Astrazeneca bicalutamide 4,636,505 Oct 1, 2008 CONDYLOX Watson Pharms podofilox 5,057,616 Oct 15, 2008 COSOPT Merck dorzolamide hydrochloride; timolol maleate 4,797,413 Oct 28, 2008 ELIGARD Qlt Usa leuprolide acetate 4,938,763 Oct […]


Drug Patent Expirations in September 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in September 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ANDRODERM Watson Labs testosterone 4,855,294 Sep 6, 2008 AVITA Mylan Bertek tretinoin 5,045,317 Sep 3, 2008 DDAVP Sanofi Aventis Us desmopressin acetate 5,047,398 Sep 10, 2008 OPANA ER Endo Pharms oxymorphone […]


Drug Patent Expirations in August 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in August 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 4,992,474 Aug 12, 2008 ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,126,375 Aug 12, 2008 ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol […]


Drug Patent Expirations in July 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in July 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration CARDIOLITE Bristol Myers Squibb technetium tc-99m sestamibi kit 4,988,827 Jul 29, 2008 DEPAKOTE Abbott divalproex sodium 4,988,731 Jul 29, 2008 DEPAKOTE Abbott divalproex sodium 5,212,326 Jul 29, 2008 DEPAKOTE CP Abbott […]


Drug Patent Expirations in June 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in June 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ADALAT CC Bayer Pharms nifedipine 4,892,741 Jun 8, 2008 CAVERJECT IMPULSE Pharmacia And Upjohn alprostadil 4,968,299 Jun 28, 2008 EFFEXOR Wyeth Pharms Inc venlafaxine hydrochloride 4,535,186 Jun 13, 2008 EFFEXOR XR […]